Delivery Order 75N93021D00018-75N93024F00001

Award Date 9/27/24
Potential Completion Date 1/26/26
Potential Value $448K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Wilmington, MA 01887, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $10,359 firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Charles River Laboratories, Inc. The contract is not set aside for any small business programs. Charles River Laboratories is a global contract research organization that provides essential products and services to support pharmaceutical, biotechnology, and government research and development efforts. Under this contract, Charles River will provide a range of...
This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Charles River Laboratories, Inc. The $237,634.10 contract is for laboratory and animal research-related services in support of biomedical research and public health initiatives. Charles River is a global contract research organization that provides essential products and services for pharmaceutical, biotechnology, and...
This $186,389.10 firm fixed-price delivery order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Charles River Laboratories, Inc. to manufacture and safety test experimental virus vaccines. The contract, which does not have a set-aside designation, was awarded on February 10, 2015 with an ultimate completion date of August 9, 2016. Charles River Laboratories is a global contract research organization...
This is a $525,975.60 firm-fixed-price delivery order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Charles River Laboratories, Inc. for the provision of clinical trial materials for virus vaccines. The contract has a completion date of December 31, 2024 and was not set aside for any specific business type. Charles River Laboratories is a global provider of essential products and services to support drug discovery,...
This is a $184,775.40 firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Charles River Laboratories, Inc. for the manufacture and safety testing of experimental virus vaccines. The contract has an ultimate completion date of December 31, 2014 and does not have a set-aside designation. Charles River Laboratories is a global contract research organization that provides specialized products and services to support government...
This is a $178,761.60 firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Charles River Laboratories, Inc. to manufacture and safety test experimental virus vaccines. The contract has no set-aside designation. Charles River is a global contract research organization that provides specialized research products and services to government agencies, including laboratory animals, diagnostic testing, virus...
This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Charles River Laboratories, Inc. (doing business as Charles River) for the manufacture and safety testing of experimental virus vaccines. The contract has a ceiling value of $180,478.80 and is a firm fixed-price delivery order with a final completion date of July 31, 2020. The contract was not set aside for any specific business type. Through this award, Charles River,...
This is a $8,232 firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Charles River Laboratories, Inc. (Charles River) on February 27, 2019. The contract has an ultimate completion date of February 26, 2025 and does not utilize a set-aside designation. Charles River is a global contract research organization that provides essential products and services to support pharmaceutical, biotechnology, and government research and development...
This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Charles River Laboratories, Inc. to manufacture and safety test experimental virus vaccines. The contract has a ceiling value of $5,147.10 and runs through November 11, 2015. There is no set-aside designation for this award. Charles River Laboratories is a global contract research organization that provides...
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Charles River Laboratories, Inc. The contract has a ceiling value of $4,287.60 and does not have a set-aside designation. Charles River Laboratories, a global contract research organization, is providing research-related products and services to support NIH's biomedical research and public health initiatives. This includes...
  • 75N93021D00018
    Indefinite Delivery Contract
  • 75N93021D00018-75N93024F00001
    Delivery Order

This $448,478 firm fixed-price delivery order contract was awarded to Charles River Laboratories, Inc. (doing business as Charles River) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract, which has an ultimate completion date of January 26, 2026, is for the provision of influenza challenge virus under Task Order 10. Charles River is a global contract research organization that provides essential products and services to support pharmaceutical, biotechnology, and government research and development efforts. The contract does not have a set-aside designation. Charles River has been awarded numerous prime and subcontracts by federal agencies to provide specialized research products and services, including laboratory animals, diagnostic testing, virus vaccines, and cell banks critical for biomedical research and public health initiatives.

Generated 9/28/24, 10:40 AM